BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3280609)

  • 1. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
    Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
    J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 4. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter pyloridis is not responsible for duodenal ulcer formation: results of a controlled therapeutic trial.
    Kumar N; Anand BS
    J Assoc Physicians India; 1988 Feb; 36(2):137-9. PubMed ID: 3053613
    [No Abstract]   [Full Text] [Related]  

  • 6. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone.
    Bianchi Porro G; Parente F; Lazzaroni M
    Gut; 1993 Apr; 34(4):466-9. PubMed ID: 8491391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
    Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
    Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
    Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
    Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
    O'Riordan T; Mathai E; Tobin E; McKenna D; Keane C; Sweeney E; O'Morain C
    Gut; 1990 Sep; 31(9):999-1002. PubMed ID: 2210469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
    Rauws EA; Tytgat GN
    Lancet; 1990 May; 335(8700):1233-5. PubMed ID: 1971318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
    Pan SA; Liao CH; Lien GS; Chen SH
    Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
    Hu FL; Jia BQ; Gao HZ
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.
    Humphreys H; Bourke S; Dooley C; McKenna D; Power B; Keane CT; Sweeney EC; O'Moráin C
    Gut; 1988 Mar; 29(3):279-83. PubMed ID: 3356357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
    Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Campylobacter pylori and recurrence of duodenal ulcer. A six-month follow-up study.
    Mouzas IA; Kalantzis N; Gabriel P; Kallimanis G; Papantoniou P; Mavrogiannis H
    Acta Gastroenterol Latinoam; 1990; 20(3):159-61. PubMed ID: 2095099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori.
    Coghlan J; Hutchinson L; Gilligan D; McKenna D; Keane C; Sweeney E; O'Morain C
    Aliment Pharmacol Ther; 1990 Feb; 4(1):49-54. PubMed ID: 2104073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.
    Coghlan JG; Gilligan D; Humphries H; McKenna D; Dooley C; Sweeney E; Keane C; O'Morain C
    Lancet; 1987 Nov; 2(8568):1109-11. PubMed ID: 2890019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.